A Mitochondria Researcher Went Looking for Evidence to Support Zone 2. Here Is What She Found.

Introduction: The Question a Mitochondria Researcher Asked About Her Own Training

Kristi Storoschuk spends her professional life studying mitochondria. As a PhD researcher at Queens University's muscle physiology lab, her work focuses on the molecular regulation of mitochondrial biogenesis, specifically how carbohydrate availability and exercise intensity interact to drive the cellular adaptations that determine metabolic health. She is, by any reasonable measure, closer to the science of mitochondrial adaptation than almost anyone participating in the zone 2 conversation online.

And yet, like millions of other people who engage with longevity and fitness content on social media, she found herself feeling that she should be doing zone 2.

The message was everywhere. Respected researchers, medical doctors with large audiences, and longevity-focused podcasters were all delivering a consistent prescription: if you care about your mitochondrial health, your fat oxidative capacity, and your long-term metabolic function, you need to be spending significant time training in zone 2. Hours of it, multiple days per week, at an intensity low enough to hold a conversation and keep your blood lactate below 2 millimoles per liter. The message was delivered with conviction and by people Storoschuk respected. She felt uncomfortable questioning it.

The problem was that when she brought the idea to her supervisor, Dr. Brendan Gurd, the textbook physiology of mitochondrial adaptation did not line up with what she was hearing. The molecular signals that trigger mitochondria to grow, multiply, and become more efficient are generated when the cell is stressed beyond its current aerobic capacity. Low intensity exercise, by definition, does not do that. The body handles it comfortably by burning fat without triggering the stress responses that drive adaptation. That is not a fringe position. It is foundational exercise physiology. And yet the zone 2 messaging implied that precisely this kind of low intensity, fat-burning exercise was the key to mitochondrial health.

Rather than dismissing the online consensus or accepting it uncritically, Storoschuk and her team did what scientists are supposed to do when claims outrun their evidence base: they went looking for the studies. What they found, or more precisely what they did not find, became the basis of a narrative review that has generated considerable discussion in the longevity and fitness research community since its publication.

In a recent episode of the Beyond Healthspan podcast, Storoschuk joined Dr. Richard LaFountain and Brandon Fell to discuss what the review found, what it means for how most people should think about their exercise time, and why the zone 2 story, compelling as it sounds, may be built on a foundation considerably thinner than its prominence in the longevity conversation suggests. This companion piece distills the most important arguments from that conversation. For the full depth of their discussion, including a fascinating detour into Storoschuk's work validating blood-based markers of muscle quality, the episode itself is essential viewing.

What follows is not an argument that zone 2 is useless. It is an argument that the evidence for its specific claims has been overstated, and that for most people with limited time to invest in exercise, intensity deserves considerably more of that time than the zone 2 narrative currently gives it.

What Zone 2 Actually Is, and Why Defining It Is Harder Than It Sounds

Before examining what the evidence does and does not support about zone 2, it helps to understand what zone 2 actually is, because the answer is less straightforward than the confident tone of most zone 2 content suggests.

Exercise intensity exists on a continuum, but physiologists divide that continuum into three distinct domains based on the body's metabolic responses at each level. The first domain is moderate intensity, where the body can meet its energy demands comfortably through aerobic metabolism and blood lactate remains stable at low levels. The second is heavy intensity, where lactate begins to accumulate faster than it can be cleared, creating a new elevated but still manageable steady state. The third is severe intensity, where lactate accumulates continuously and exercise can only be sustained for a limited time before fatigue sets in. These three domains are defined by real physiological transitions in how the body is generating and clearing energy, which is what makes them scientifically meaningful rather than arbitrary divisions.

Zone 2, as it is discussed in longevity and fitness content, sits in the first of these three domains, just below the transition into the heavy intensity zone. It is characterized by a conversational pace, a heart rate that is elevated but not demanding, and a metabolic state in which fat is the predominant fuel source. The blood lactate threshold that most precisely defines its upper boundary is 2 millimoles per liter, which is the physiological marker at which the body begins transitioning from the moderate to the heavy intensity domain.

The problem is that zone 2 does not exist as a term in the way the coaching world uses it. Within the five to seven zone models that have become standard in endurance coaching, zone 2 is a specific band above zone 1 and below zone 3. But across different coaching systems, different measurement tools, and different individual physiologies, the absolute intensity that corresponds to zone 2 varies enormously. A paper published earlier this year tested multiple common definitions of zone 2 against each other and found that they pointed to meaningfully different absolute intensities. Two people both training in zone 2 by their respective definitions may be working at genuinely different effort levels, engaging different metabolic systems, and producing different physiological stimuli.

This definitional variability is not a minor technical footnote. It has significant consequences for how the research evidence is interpreted. The most important of these consequences is the distinction between zone 2 as defined physiologically, below 2 millimoles per liter of blood lactate, and moderate intensity continuous training as it appears in most published research. As Storoschuk was careful to clarify in the episode, moderate intensity continuous training in research studies is typically prescribed at intensities above zone 2. When researchers report that moderate intensity exercise produces mitochondrial benefits, or when meta-analyses conclude that endurance training produces similar adaptations to high intensity interval training over longer timeframes, they are generally not studying zone 2. They are studying intensities that most zone 2 advocates would classify as zone 3 or higher.

This distinction matters enormously for the evidence base. A great deal of the research that has been cited in support of zone 2 does not actually study zone 2. It studies moderate intensity exercise at intensities that exceed the physiological definition of zone 2, and the benefits observed in that research cannot be straightforwardly attributed to training in the specific low intensity band that zone 2 describes. When Storoschuk and her team went looking specifically for studies that prescribed exercise at genuine zone 2 intensities and measured mitochondrial outcomes, the literature was considerably thinner than the confidence of online zone 2 advocates would suggest.

Measuring zone 2 precisely requires tools that most people do not have convenient access to. Blood lactate testing, the most physiologically accurate method, requires a lactate meter, a finger prick, and the discipline to test regularly, though as the episode noted, a lactate meter can be purchased for around three hundred dollars, making it more accessible than many people assume. Heart rate, perceived exertion, ventilation rate, and the talk test are all practical approximations, but they introduce variability that makes it difficult to know with confidence whether any given training session is actually in zone 2 or has drifted above it. For the purposes of this discussion, and consistent with Storoschuk's review, zone 2 refers specifically to the physiologically defined low intensity domain below the first lactate threshold, not the broader category of moderate exercise that the term is often used to describe.

Where Zone 2 Came From and Why the Evidence Is Thinner Than the Hype

Understanding why zone 2 became so prominent in the longevity conversation requires tracing the logic that made it seem self-evidently correct, because the argument is not unreasonable on its surface. It simply does not hold up when examined carefully.

The starting point is elite endurance athletes. Cyclists, marathon runners, triathletes, and cross-country skiers at the highest levels of competition share a distinctive physiological profile. They have extraordinarily high mitochondrial content in their muscle tissue. They oxidize fat at rates that recreational athletes cannot approach. They are remarkably insulin sensitive and metabolically healthy by virtually every measure. And they spend, by most accounts, somewhere around 80% of their training time at low intensities that fall within or near zone 2. The observation that these exceptional athletes do enormous volumes of low intensity training became the foundation of the zone 2 argument: if elite athletes do this much zone 2, and elite athletes have the mitochondrial health we are trying to achieve, then zone 2 must be what produces it.

The logical error in this reasoning is one that Storoschuk identified clearly in the episode, and it is worth stating precisely. Elite endurance athletes train approximately 40 hours per week. Eighty percent of 40 hours is 32 hours of low intensity training per week. But 20% of 40 hours is 8 hours of high intensity training per week. Eight hours of high intensity exercise per week is more than most recreational athletes accumulate across all training zones combined. When researchers and commentators attribute the mitochondrial profile of elite athletes to the 80% spent in zone 2, they are ignoring the fact that the 20% spent at high intensity represents an absolute volume of intense training stimulus that is itself extraordinary by any normal standard.

This is the attribution error at the heart of the zone 2 argument. The polarized training model, which describes the 80/20 split that elite athletes tend to follow, has been interpreted as evidence that zone 2 is the engine of their adaptation. But the adaptations may be coming primarily from the 20%, with the 80% serving a recovery, volume maintenance, and aerobic base function that is relevant specifically because of the volume of high intensity work being layered on top of it. Attributing elite mitochondrial health to zone 2 because elite athletes do a lot of zone 2 is a little like attributing elite athletic performance to sleep because elite athletes sleep a lot. The sleep is real and important, but it is not the stimulus producing the adaptation.

When Storoschuk and her team went looking for direct evidence that zone 2, as physiologically defined, produces superior mitochondrial adaptations compared to higher intensities, the literature offered very little support. The review found a handful of studies with results favorable to zone 2 and a considerably larger body of evidence pointing in the other direction. When low and high intensity exercise are compared directly for mitochondrial outcomes, higher intensity exercise consistently produces greater adaptations. There is very little evidence that zone 2 specifically produces something biologically unique that higher intensities cannot produce more efficiently.

The more important finding from the review was a threshold effect identified in a 2018 meta-analysis by Granada and colleagues. Their pooled analysis of the available evidence suggested that mitochondria adapt most robustly when exercise exceeds approximately 65% of work rate maximum, and that below this threshold the adaptive signal is insufficient to drive meaningful mitochondrial biogenesis. Zone 2, by its physiological definition, falls below this threshold for most individuals. This does not mean zone 2 does nothing. It means that the intensity is not high enough to reliably trigger the molecular cascade that the zone 2 narrative presents it as uniquely capable of triggering.

The social dynamics that drove zone 2 into the longevity conversation are worth noting alongside the scientific evidence. Zone 2 is, as the episode observed with some humor, a nearly perfect format for podcast content. It pairs naturally with audio consumption, it is accessible to people across a wide range of fitness levels, it sounds scientific and specific in a way that generic exercise advice does not, and it was championed by highly credible voices in the longevity space whose broader work commands genuine respect. The zone 2 message spread through a media ecosystem that was primed to receive it, carried by the credibility of the people delivering it rather than the depth of the evidence beneath it.

Storoschuk was careful in the episode to note that she found this dynamic genuinely uncomfortable. She respected the people making the zone 2 argument and was reluctant to question them. That reluctance is worth naming, because it reflects something real about how health and fitness information propagates. When credible experts make confident claims, the appropriate response, in science as in life, is to ask for the evidence. What her review found was that the evidence for the specific claims being made about zone 2 and mitochondrial health is considerably thinner than the confidence with which those claims have been delivered.

The Intensity Threshold and Why the Exercise Pyramid May Be Upside Down

The most counterintuitive argument in Storoschuk's review, and the one that most directly challenges the zone 2 narrative, is the mechanistic case for why low intensity exercise may be insufficient to drive the mitochondrial adaptations it is credited with producing. Understanding this argument requires stepping back from training zones and looking at how mitochondria actually respond to exercise at the cellular level.

Mitochondria are the primary site of aerobic energy production in the cell. They take in oxygen and fuel substrates, primarily fat and carbohydrate, and convert them into ATP, the molecular currency the body uses to power virtually every biological process. What most people do not fully appreciate is that mitochondria do not adapt simply because they are being used. They adapt when they are stressed. Specifically, they respond to situations in which the demand for ATP exceeds the current capacity of the aerobic system to supply it. When that gap opens up, the cell generates molecular signals that tell it to build more mitochondria, improve their efficiency, and expand the enzymatic machinery that supports fat and carbohydrate oxidation. Without that stress signal, the adaptive machinery stays quiet.

This is the mechanistic problem with zone 2 that Storoschuk's supervisor immediately identified when she first raised the topic. At low intensities, the body can meet its energy demands almost entirely through fat oxidation without pushing the aerobic system anywhere near its limits. The mitochondria are being used, but they are not being stressed. They are operating well within their current capacity, handling the energy demand comfortably, and generating none of the signals that would tell them to grow and improve. As Storoschuk put it in the episode, burning fat during exercise does not make you better at burning fat. What makes you better at burning fat is overloading the system above its current aerobic ceiling so that mitochondria are forced to expand their capacity to meet the demand.

The signals that drive mitochondrial biogenesis are generated when exercise intensity pushes into and above the heavy intensity domain, when glycolysis ramps up to supplement fat oxidation, when lactate begins to accumulate, and when the cell's energy sensors detect that aerobic capacity is being genuinely taxed. These are the conditions that activate the molecular pathways responsible for mitochondrial adaptation, including AMPK, which detects energy stress, and PGC-1 alpha, often described as the master regulator of mitochondrial biogenesis. Zone 2 does not reliably activate these pathways because it does not reliably create the energy stress that activates them.

The practical implication is captured in what Storoschuk described as pulling versus pushing the lactate threshold. The zone 2 narrative suggests that training consistently at zone 2 will gradually push your zone 2 intensity upward, allowing you to work harder at the same heart rate over time. Storoschuk argues the physiology points in the opposite direction: you cannot push your lactate threshold up from below. You have to pull it up from above, by working at intensities that stress the system beyond its current aerobic capacity, forcing it to adapt, and thereby shifting the threshold upward as a consequence. Zone 2 training, in this framing, is not the driver of adaptation. It is a consequence of having already done the harder work of building a more capable aerobic system.

This leads to the inverted pyramid argument that generated considerable discussion in the episode. The conventional zone 2 framing imagines exercise programming as a pyramid with a wide base of low intensity work supporting a narrower layer of moderate intensity and a small peak of high intensity. The logic is that you build your aerobic base first, develop your fat oxidative capacity, and then add intensity on top of that foundation. Storoschuk's argument, grounded in what the molecular evidence shows about mitochondrial adaptation, is that this pyramid is upside down. The right starting point is intensity, and zone 2 is something you earn by first exhausting your recoverable capacity for higher intensity work.

Recoverable volume is the key concept here. There is a ceiling on how much high intensity exercise any individual can do and still recover from adequately. Push beyond that ceiling and performance declines, sleep deteriorates, and the risk of overreaching or injury increases. But for most members of the general population, that ceiling is considerably higher than where they currently are. The vast majority of recreational exercisers have significant capacity for additional high intensity work that they are not currently using. The zone 2 narrative, by directing that unused capacity toward low intensity exercise, may be redirecting people away from the stimulus that would produce the adaptations they are actually seeking.

The practical test for whether you have genuinely reached your recoverable volume of high intensity exercise is not a complicated calculation. It is the question of whether your recovery markers, sleep quality, resting heart rate, heart rate variability, and subjective energy levels, are telling you that you are under a training load your body is managing well. For most people who have never pushed their high intensity training volume to its recoverable limit, those markers will remain stable well beyond where the zone 2 prescription would have them stop. Only when those signals begin to indicate accumulated fatigue does the case for pulling back to lower intensities become genuinely compelling.

None of this is an argument for exercising at maximum intensity every session. Progressive overload, recovery, and the avoidance of injury are real constraints that exercise programming has to respect. The argument is simply that the sequence matters. Intensity first, in amounts that can be recovered from. Zone 2, if and when it fits into a program, as a complement to higher intensity work rather than its foundation or its replacement.

Three Scenarios and What the Evidence Suggests for Each

The abstract argument for prioritizing intensity over zone 2 is one thing. Translating it into practical guidance for people at genuinely different fitness levels is another. In the episode, Dr. LaFountain and Brandon Fell walked through three scenarios that capture most of the range of people likely to encounter the zone 2 conversation, and Storoschuk's responses to each illustrate how the evidence applies differently depending on where someone is starting from.

The Non-Exerciser or Less Fit Individual

This is the person most commonly prescribed zone 2 as a starting point, and the prescription has an intuitive appeal. Zone 2 is accessible, low impact, sustainable for long durations, and carries a lower risk of injury than higher intensity exercise. For someone who has not been exercising regularly, the argument goes, building a zone 2 base is the sensible first step before adding intensity.

Storoschuk's position challenges this framing directly. Her argument is that the less fit someone is and the less time they have available to exercise, the more important it is to prioritize intensity within whatever they are able to do. For a person who is significantly deconditioned, even relatively modest increases in exercise intensity above a comfortable walking pace will generate the metabolic stress needed to drive adaptation. Staying at true zone 2, which for a less fit person may feel more effortful than it does for a trained individual due to a lower lactate threshold, keeps them in a range where the adaptive signal is weakest.

The practical prescription she offers is not to launch deconditioned individuals into aggressive interval training. It is to introduce intervals of higher effort within sessions that are otherwise accessible. Walking from lamp post to lamp post and then picking up the pace between the next two. Alternating between comfortable effort and brief periods of huffing and puffing. These modest intensity variations, even within a session that looks broadly like a zone 2 workout, generate more adaptive stimulus than staying consistently in the low intensity zone for the same duration.

Critically, Storoschuk is clear that going from nothing to something is the single most important step any non-exerciser can take, and that the mortality data strongly supports this. The benefit of transitioning from sedentary to active is larger than any subsequent increment in training quality or intensity. Zone 2 is considerably better than nothing, and if it is what gets someone exercising consistently, it has genuine value. But the goal, even for beginners, should be to incorporate intensity as soon as it is safely achievable rather than spending extended periods in the low intensity range waiting until some threshold of base fitness has been established.

The Recreational Active Individual

This is perhaps the most practically important scenario for the longevity audience, because it describes the largest group of people currently following zone 2 prescriptions. These are people who exercise regularly, take their health seriously, and have structured their training around the zone 2 advice they have encountered from trusted sources. They are not sedentary. They are putting in the time. And according to the evidence Storoschuk's review identified, they may be getting considerably less mitochondrial and cardiovascular return on that time investment than they believe.

Dr. LaFountain offered a clinical illustration that anchors this scenario in a real-world consequence. A client came to him after having their VO2 max tested for the first time in roughly two years. In the intervening period, this person had been exercising consistently, following a predominantly zone 2 focused program informed by the longevity content they consumed. Their VO2 max had declined more than expected for the amount of time that had elapsed, more than could be easily attributed to the aging-related decline that occurs even in active individuals. The decline appeared to reflect not a failure of consistency but a failure of intensity, consistent exercise at insufficient stimulus to maintain, let alone improve, cardiovascular fitness over time.

The solution was straightforward: introduce one to two sessions of higher intensity exercise per week alongside the existing training. Not replacing the lower intensity work entirely, but ensuring that the training program included enough intensity to provide an adequate stimulus for cardiovascular adaptation. The expectation, grounded in what the research shows about VO2 max response to intensity, was that the next test would reflect meaningful improvement.

This scenario illustrates the specific risk of the zone 2 prescription for recreational exercisers: it can create a false sense of progress through consistency without producing the physiological improvements that consistency is assumed to be generating. Putting in the hours feels like doing the work. But if the intensity is insufficient to trigger the molecular signals that drive mitochondrial and cardiovascular adaptation, the hours accumulate without producing the outcomes they are believed to be producing.

The Elite or High Volume Athlete

This is the only scenario in which a substantial zone 2 investment is clearly and unambiguously justified by the evidence. Elite endurance athletes train at volumes that most people cannot imagine sustaining, and at those volumes the constraint on training becomes recovery rather than stimulus. When an athlete is already generating 8 hours per week of high intensity training stimulus alongside 32 hours of lower intensity work, they have genuinely earned their zone 2. They have maxed out their recoverable high intensity volume. Adding more intensity would tip them into overreaching. The lower intensity work allows them to maintain training volume, support aerobic capacity, and accumulate the total energy expenditure that their performance demands without exceeding their recovery ceiling.

For elite athletes, zone 2 is not a mitochondrial stimulus. It is a recovery tool that allows more high intensity work to be sustained over time. Understanding it that way reframes its role entirely. It is not what produces their exceptional mitochondrial health. It is what allows them to keep doing the high intensity work that does.

The important implication for everyone who is not an elite athlete is that the zone 2 prescription was developed in a context that does not apply to them. The 80/20 polarized training model makes sense for athletes whose 20% already represents an extraordinary high intensity volume. It does not translate straightforwardly to recreational exercisers whose 20% of a much smaller total training volume represents a very small amount of high intensity work, and whose 80% zone 2 investment may be directing the majority of their limited exercise time toward the least effective portion of the training stimulus.

The actionable question for anyone trying to locate themselves within these three scenarios is not which zone they should be training in. It is how much intensity they are currently accumulating and whether there is recoverable capacity for more. For most people who are not elite athletes, the answer to the second question is almost certainly yes.

What Zone 2 Is Actually Good For, and When It Makes Sense

Having spent considerable time on what the evidence does not support about zone 2, it is worth being equally precise about what it does support, because Storoschuk's review was not a dismissal of low intensity exercise. It was a challenge to specific claims about its superiority for mitochondrial adaptation. Those are meaningfully different arguments, and conflating them would misrepresent both the science and the practical guidance that follows from it.

Zone 2 is not useless. It is better than nothing, considerably so. Increasing energy expenditure through any form of movement has well-documented health benefits, and the mortality data consistently shows that the transition from sedentary to active produces the largest single improvement in health outcomes of any behavioral change most people can make. Zone 2, or anything approximating it, contributes to that transition. For people who are currently inactive, a consistent zone 2 walking or cycling routine is a meaningful and valuable starting point, even if it is not the optimal stimulus for mitochondrial adaptation.

For people who are already active, zone 2 has a legitimate role as a complement to higher intensity training. Lower intensity sessions support recovery between harder efforts, allow training volume to be maintained without adding to the accumulated fatigue that high intensity work generates, and provide an opportunity to develop movement efficiency and aerobic capacity in ways that do not place excessive demand on the recovery systems. Endurance athletes have known this for decades. The question is not whether zone 2 has a place in a well-designed training program. It is whether it deserves the foundational priority that the longevity conversation has assigned to it.

There is also a dimension of zone 2 that the research does not fully capture but that the episode acknowledged honestly: its psychological and lifestyle value. Zone 2 is genuinely compatible with podcasts, phone calls, and other activities that make long duration exercise more sustainable for people with demanding schedules. It is lower impact than higher intensity exercise, which matters for people managing joint issues, recovering from injury, or simply navigating the wear and tear that accumulates with age. It produces a mood-enhancing, stress-reducing physiological state that many people find genuinely valuable independent of any specific training adaptation. These are real benefits that deserve acknowledgment even in an evidence-based assessment that questions the mitochondrial claims.

What zone 2 is not, according to the available evidence, is a superior or uniquely effective stimulus for mitochondrial biogenesis in the general population. It does not appear to produce mitochondrial adaptations that cannot be achieved more efficiently at higher intensities. It does not appear to sit below the threshold intensity needed to generate the molecular signals that drive the cellular changes the zone 2 narrative attributes to it. And it does not appear to be the mechanism through which elite athletes developed the mitochondrial health that made them the model for the zone 2 prescription in the first place.

The VO2 max data adds an important dimension to this conclusion that Storoschuk raised explicitly in the episode. VO2 max, the maximum rate at which the body can consume and utilize oxygen during exercise, is one of the strongest predictors of all-cause mortality in the epidemiological literature. Its correlation with longevity is more consistent and more robust than the mitochondrial data that underpins most zone 2 advocacy. And the evidence that higher intensity exercise drives VO2 max improvements more effectively than low intensity exercise is substantial and well-established. For anyone whose primary motivation for exercise is living longer and maintaining functional capacity into later decades of life, VO2 max may be the single most important fitness metric to optimize, and optimizing it points toward intensity rather than away from it.

This does not mean that every exercise session should be a maximum effort. The body adapts to stress, but it also requires recovery from it. A sustainable exercise program for long-term health is one that includes sufficient intensity to drive adaptation, sufficient volume to maintain aerobic capacity, and sufficient recovery to allow both of those things to happen without accumulating fatigue that undermines them. Zone 2 can legitimately occupy a portion of that program, particularly for people who have built enough higher intensity training into their routine that additional high intensity sessions would compromise their recovery. But it belongs in that program as a complement to intensity, not as its foundation or its replacement.

Perhaps the most useful reframe for zone 2 comes from Storoschuk's own language in the episode: you earn zone 2. You earn it by first exhausting your recoverable capacity for higher intensity work, by building enough intensity into your training that adding more would tip you into overreaching, and by reaching a point where lower intensity sessions are genuinely the most productive use of the training time that remains. For most members of the general population, that point is considerably further away than the zone 2 conversation implies. Getting there is the goal. Zone 2 is one of the tools available once you have.

Conclusion: The Actionable Takeaway

Zone 2 training did not become one of the most discussed concepts in longevity and fitness because the people promoting it were careless or uninformed. It became prominent because the argument for it is coherent, the people making it are credible, and the conclusion, that a comfortable, sustainable, fat-burning exercise modality is the key to mitochondrial health, is exactly the kind of finding that resonates in a culture looking for accessible paths to better health. The problem, as Storoschuk's review documented, is that the evidence beneath that argument is considerably thinner than the confidence with which it has been delivered.

What the research actually shows is more nuanced and, for most people, more demanding. Mitochondria adapt to stress, not to use. The molecular signals that drive mitochondrial biogenesis are generated when exercise intensity exceeds the current aerobic capacity of the system, not when it operates comfortably within it. Higher intensity exercise consistently produces greater mitochondrial adaptations than zone 2 in direct comparisons. The threshold above which mitochondrial adaptation reliably occurs appears to sit above where zone 2 falls for most individuals. And the VO2 max data, which carries stronger mortality correlation than the mitochondrial evidence underpinning zone 2 advocacy, points even more clearly toward intensity as the priority for anyone exercising with longevity in mind.

None of this means zone 2 has no value. It does. It is better than nothing. It supports recovery between harder sessions. It is accessible, sustainable, and compatible with the kind of lifestyle constraints that make higher intensity exercise difficult to fit into every week. For elite athletes who have genuinely exhausted their recoverable high intensity volume, it is an essential component of a well-designed training program. And for anyone who finds higher intensity exercise aversive enough that the alternative is not exercising at all, zone 2 is a valid and valuable choice. The goal is consistent movement. Zone 2 gets people moving consistently. That matters.

But for the recreational exerciser who has structured their training around zone 2 because credible voices told them it was the foundation of mitochondrial health, the evidence suggests a reallocation of training time is worth considering. Not abandoning lower intensity work entirely. Not launching into daily maximum effort sessions. Simply asking the question Storoschuk's review implicitly poses: how much intensity am I currently accumulating, and is there recoverable capacity for more? For most people, the answer to the second part of that question is yes, and acting on that answer is likely to produce meaningfully better outcomes than adding more hours in zone 2.

Storoschuk's actionable message from the episode is worth quoting directly in its simplicity: be consistent, move your body frequently, and push the intensity whenever you can. If you feel good, go for it. Do not hold back because someone online told you that you have to stay in zone 2 to protect your mitochondria. If zone 2 is what you enjoy and what keeps you exercising consistently, it is the right choice for you. If you have the capacity for more intensity and are currently directing that capacity toward low intensity training because you believe zone 2 is doing something uniquely valuable for your cellular health, the evidence suggests you are leaving meaningful adaptation on the table.

Resistance training deserves a place in this conversation too, even though Storoschuk's review focused specifically on aerobic exercise and mitochondrial outcomes. The total exercise budget is finite. How it is allocated across aerobic intensity, lower intensity aerobic work, and resistance training will determine the full range of health and longevity outcomes that exercise can produce. Resistance training's role in preserving muscle mass, maintaining strength and power, and supporting the functional independence that matters most in later decades of life means it competes directly with zone 2 for time that many people have in limited supply. The case for prioritizing intensity in aerobic training is, in part, a case for preserving time that might otherwise be spent on zone 2 for resistance training and higher intensity work that the evidence more consistently supports.

For the full depth of this conversation, including the nuances that a companion piece cannot fully capture and a fascinating discussion of the blood-based muscle quality validation work that Storoschuk and colleagues are developing, the Beyond Healthspan episode with Kristi Storoschuk, Dr. Richard LaFountain, and Brandon Fell is essential viewing. The science of exercise and mitochondrial adaptation is more complex, more interesting, and ultimately more empowering than the zone 2 narrative has made it seem. The evidence is worth understanding on its own terms, and this episode is one of the better places to start.